155 related articles for article (PubMed ID: 11893940)
1. Troglitazone stimulates pancreatic growth in normal rats.
Jia DM; Otsuki M
Pancreas; 2002 Apr; 24(3):303-12. PubMed ID: 11893940
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats.
Jia DM; Fukumitsu KI; Tabaru A; Akiyama T; Otsuki M
Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1332-40. PubMed ID: 11294751
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone prevents fatty changes of the liver in obese diabetic rats.
Jia DM; Tabaru A; Akiyama T; Abe S; Otsuki M
J Gastroenterol Hepatol; 2000 Oct; 15(10):1183-91. PubMed ID: 11106100
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis.
Shimizu K; Shiratori K; Hayashi N; Kobayashi M; Fujiwara T; Horikoshi H
Pancreas; 2002 Mar; 24(2):184-90. PubMed ID: 11854624
[TBL] [Abstract][Full Text] [Related]
5. Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus.
Shimizu K; Shiratori K; Hayashi N; Fujiwara T; Horikoshi H
Pancreas; 2000 Nov; 21(4):421-6. PubMed ID: 11075998
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
Jia DM; Tabaru A; Nakamura H; Fukumitsu KI; Akiyama T; Otsuki M
Metabolism; 2000 Sep; 49(9):1167-75. PubMed ID: 11016899
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats.
Kosegawa I; Chen S; Awata T; Negishi K; Katayama S
Clin Exp Hypertens; 1999 Apr; 21(3):199-211. PubMed ID: 10225476
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone action is independent of adipose tissue.
Burant CF; Sreenan S; Hirano K; Tai TA; Lohmiller J; Lukens J; Davidson NO; Ross S; Graves RA
J Clin Invest; 1997 Dec; 100(11):2900-8. PubMed ID: 9389757
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
Ma LJ; Marcantoni C; Linton MF; Fazio S; Fogo AB
Kidney Int; 2001 May; 59(5):1899-910. PubMed ID: 11318962
[TBL] [Abstract][Full Text] [Related]
12. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
[TBL] [Abstract][Full Text] [Related]
14. Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
Kitakoshi K; Oshida Y; Nakai N; Han YQ; Sato Y
Horm Metab Res; 2001 Jun; 33(6):365-9. PubMed ID: 11456287
[TBL] [Abstract][Full Text] [Related]
15. Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance.
Yagi N; Takasu N; Higa S; Ishikawa K; Murakami K; Mimura G
Horm Metab Res; 1995 Oct; 27(10):439-41. PubMed ID: 8575720
[TBL] [Abstract][Full Text] [Related]
16. Effects of type-2 diabetes and troglitazone on the expression patterns of small intestinal sugar transporters and PPAR-gamma in the Zucker diabetic fatty rat.
Corpe C; Sreenan S; Burant C
Digestion; 2001; 63(2):116-23. PubMed ID: 11244250
[TBL] [Abstract][Full Text] [Related]
17. Effect of troglitazone on blood insulin levels after pancreas transplantation with systemic venous drainage in rats.
Uchiyama K; Nakai I; Shimizu Y; Mitsuo M; Yasunami Y; Oka T
Transplantation; 1997 Nov; 64(10):1476-8. PubMed ID: 9392315
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
[TBL] [Abstract][Full Text] [Related]
19. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone treatment of aging Brown Norway rats improves food intake and weight gain after fasting without increasing hypothalamic NPY gene expression.
Wolden-Hanson T; Marck BT; Matsumoto AM
Exp Gerontol; 2002 May; 37(5):679-91. PubMed ID: 11909685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
